Argenx

Stories

• Argenx halts major drug trial as sector splits

  12 October 2026Dutch-Belgian biotechnology company specializing in antibody therapies
• 

  Lab Wins Clashed with Epidemic Reality

  11 October 2026Biotechnology company developing autoimmune antibody treatments